HIF1A and glioblastoma: Interestingly, Bao and colleagues demonstrated that within glioblastoma cells methylation of this residue or mutation to arginine did not alter promotor occupancy of p300 nor the binding of p300 and other co-regulators to HIF1α (Bao et al., 2018).